Hematology NewsTP53 mutations could help stratify MCL patientsNovember 10, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsLenalidomide shows clinical activity in relapsed/refractory MCLNovember 10, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves acalabrutinib for second-line treatment of MCLOctober 31, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIrradiation safe, effective as chemotherapy before cell transplant in mantle cell lymphomaOctober 23, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsRare type of MCL mimics Castleman diseaseOctober 6, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsVCR regimen showed efficacy in mantle cell and indolent lymphomasOctober 6, 2017Mantle Cell LymphomaLymphoma & Plasma Cell DisordersIndolent LymphomaFollicular Lymphoma
Hematology NewsRituximab maintenance halves MCL death risk after ASCTSeptember 27, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsPlerixafor doesn’t overcome HPC failure in R-hyperCVAD for mantle cell lymphomaSeptember 10, 2017Mantle Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Oncology PracticeFDA grants priority review of acalabrutinib for second-line treatment of MCLAugust 2, 2017Lymphoma & Plasma Cell DisordersMantle Cell Lymphoma
Hematology NewsIMiD/Anti-CD20 combo induces complete responses in r/r NHLJuly 19, 2017Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive LymphomasImmuno-oncologyFollicular Lymphoma
Hematology NewsChemo-free induction in MCL keeps getting betterJune 23, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBendamustine plus rituximab may have edge for treating indolent NHL, MCLJune 22, 2017Mantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsHitting BTK, PI3K pays off in B-cell malignanciesJune 20, 2017Mantle Cell LymphomaCLLLymphoma & Plasma Cell Disorders
Hematology NewsEarly allo SCT advised for high-risk mantle cell lymphomaMay 20, 2017Mantle Cell Lymphoma
